TABLE 4.
Prevalence Ratio of Systemic Therapy Use in the Last 30 Days of Life Before and After FDA Approval for the Five Tumor Groups With FDA Approval Before 2017, Cancer Surveillance System, and Linked Pharmacy Claims, 2011-2018
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.